Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1990 1
1991 1
1995 1
1999 1
2000 4
2001 3
2002 1
2003 3
2004 1
2005 3
2006 3
2007 4
2008 4
2009 3
2010 6
2011 1
2012 5
2013 8
2014 8
2015 16
2016 22
2017 15
2018 27
2019 47
2020 42
2021 38
2022 30
2023 35
2024 15

Text availability

Article attribute

Article type

Publication date

Search Results

308 results

Results by year

Filters applied: . Clear all
The following terms were ignored: %, %, %
The following terms were not found in PubMed: 20Mart, ADnez
Page 1
CKD therapy to improve outcomes of immune-mediated glomerular diseases.
Anders HJ, Fernandez-Juarez GM, Vaglio A, Romagnani P, Floege J. Anders HJ, et al. Nephrol Dial Transplant. 2023 Nov 8;38(Supplement_2):ii50-ii57. doi: 10.1093/ndt/gfad069. Nephrol Dial Transplant. 2023. PMID: 37218706 Review.
The management of immunoglobulin A nephropathy, membranous nephropathy, lupus nephritis, anti-neutrophil cytoplasmic antibody-associated vasculitis, C3 glomerulonephritis, autoimmune podocytopathies and other immune-mediated glomerular disorders is focused on two major tre …
The management of immunoglobulin A nephropathy, membranous nephropathy, lupus nephritis, anti-neutrophil cytoplasmic antibody-associated vas …
Clinical Profiles and Patterns of Kidney Disease Progression in C3 Glomerulopathy.
Caravaca-Fontán F, Cavero T, Díaz-Encarnación M, Cabello V, Ariceta G, Quintana LF, Marco H, Barros X, Ramos N, Rodríguez-Mendiola N, Cruz S, Fernández-Juárez G, Rodríguez A, Pérez de José A, Rabasco C, Rodado R, Fernández L, Pérez-Gómez V, Ávila A, Bravo L, Espinosa N, Allende N, Sanchez de la Nieta MD, Rodríguez E, Rivas B, Melgosa M, Huerta A, Miquel R, Mon C, Fraga G, de Lorenzo A, Draibe J, González F, Shabaka A, López-Rubio ME, Fenollosa MÁ, Martín-Penagos L, Da Silva I, Titos JA, Rodríguez de Córdoba S, Goicoechea de Jorge E, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Caravaca-Fontán F, et al. Kidney360. 2023 May 1;4(5):659-672. doi: 10.34067/KID.0000000000000115. Epub 2023 Mar 30. Kidney360. 2023. PMID: 36996481 Free PMC article.
KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and proteinuria <3.5 g/d, regardless of baseline eGFR. A faster eGFR decline in C3 glomerulopathy is associated with higher probability of k …
KEY POINTS: Kidney survival in C3 glomerulopathy is significantly higher in patients with a disease chronicity score <4 and protei …
Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1.
Klionsky DJ, Abdel-Aziz AK, Abdelfatah S, Abdellatif M, Abdoli A, Abel S, Abeliovich H, Abildgaard MH, Abudu YP, Acevedo-Arozena A, Adamopoulos IE, Adeli K, Adolph TE, Adornetto A, Aflaki E, Agam G, Agarwal A, Aggarwal BB, Agnello M, Agostinis P, Agrewala JN, Agrotis A, Aguilar PV, Ahmad ST, Ahmed ZM, Ahumada-Castro U, Aits S, Aizawa S, Akkoc Y, Akoumianaki T, Akpinar HA, Al-Abd AM, Al-Akra L, Al-Gharaibeh A, Alaoui-Jamali MA, Alberti S, Alcocer-Gómez E, Alessandri C, Ali M, Alim Al-Bari MA, Aliwaini S, Alizadeh J, Almacellas E, Almasan A, Alonso A, Alonso GD, Altan-Bonnet N, Altieri DC, Álvarez ÉMC, Alves S, Alves da Costa C, Alzaharna MM, Amadio M, Amantini C, Amaral C, Ambrosio S, Amer AO, Ammanathan V, An Z, Andersen SU, Andrabi SA, Andrade-Silva M, Andres AM, Angelini S, Ann D, Anozie UC, Ansari MY, Antas P, Antebi A, Antón Z, Anwar T, Apetoh L, Apostolova N, Araki T, Araki Y, Arasaki K, Araújo WL, Araya J, Arden C, Arévalo MA, Arguelles S, Arias E, Arikkath J, Arimoto H, Ariosa AR, Armstrong-James D, Arnauné-Pelloquin L, Aroca A, Arroyo DS, Arsov I, Artero R, Asaro DML, Aschner M, Ashrafizadeh M, Ashur-Fabian O, Atanasov AG, Au AK, Auberger P, Auner HW, Aurelian L, Autelli R… See abstract for full author list ➔ Klionsky DJ, et al. Autophagy. 2021 Jan;17(1):1-382. doi: 10.1080/15548627.2020.1797280. Epub 2021 Feb 8. Autophagy. 2021. PMID: 33634751 Free PMC article.
Biomarkers in Vestibular Schwannoma-Associated Hearing Loss.
Lassaletta L, Calvino M, Morales-Puebla JM, Lapunzina P, Rodriguez-de la Rosa L, Varela-Nieto I, Martinez-Glez V. Lassaletta L, et al. Front Neurol. 2019 Sep 18;10:978. doi: 10.3389/fneur.2019.00978. eCollection 2019. Front Neurol. 2019. PMID: 31620068 Free PMC article. Review.
Previous studies have identified perilymph proteins correlated with tumor-associated HL, including mu-Crystallin (CRYM), low density lipoprotein receptor-related protein 2 (LRP2), immunoglobulin (Ig) gamma-4 chain C region, Ig kappa-chain C region, complement C3, and immun …
Previous studies have identified perilymph proteins correlated with tumor-associated HL, including mu-Crystallin (CRYM), low density lipopro …
Screening of Exosome-Derived Proteins and Their Potential as Biomarkers in Diagnostic and Prognostic for Pancreatic Cancer.
Marin AM, Batista M, Korte de Azevedo AL, Bombardelli Gomig TH, Soares Caldeira Brant R, Chammas R, Uno M, Dias Araújo D, Zanette DL, Nóbrega Aoki M. Marin AM, et al. Int J Mol Sci. 2023 Aug 9;24(16):12604. doi: 10.3390/ijms241612604. Int J Mol Sci. 2023. PMID: 37628784 Free PMC article.
IPMN groups, highlighting proteins of the complement system and coagulation, such as C3, APOB, and SERPINA. Additionally, PDAC with no treatment showed 11 differentially expressed proteins when compared to Folfirinox neoadjuvant therapy or Gemcitabine adjuvant therapy. ...
IPMN groups, highlighting proteins of the complement system and coagulation, such as C3, APOB, and SERPINA. Additionally, PDAC with n …
Dietary Options for Rodents in the Study of Obesity.
Bastías-Pérez M, Serra D, Herrero L. Bastías-Pérez M, et al. Nutrients. 2020 Oct 22;12(11):3234. doi: 10.3390/nu12113234. Nutrients. 2020. PMID: 33105762 Free PMC article. Review.
Gongolarones as antiamoeboid chemical scaffold.
Rodríguez-Expósito RL, Nicolás-Hernández DS, Sifaoui I, Cuadrado C, Salazar-Villatoro L, Reyes-Batlle M, Hernández-Daranas A, Omaña-Molina M, Fernández JJ, Díaz-Marrero AR, Piñero JE, Lorenzo-Morales J. Rodríguez-Expósito RL, et al. Biomed Pharmacother. 2023 Feb;158:114185. doi: 10.1016/j.biopha.2022.114185. Epub 2023 Jan 9. Biomed Pharmacother. 2023. PMID: 36916403 Free article.
Update on genetics of postprandial lipemia.
Perez-Martinez P, Delgado-Lista J, Perez-Jimenez F, Lopez-Miranda J. Perez-Martinez P, et al. Atheroscler Suppl. 2010 Jun;11(1):39-43. doi: 10.1016/j.atherosclerosissup.2010.03.002. Atheroscler Suppl. 2010. PMID: 20434407 Review.
In this study we have presented the current evidence linking a number of candidate genes (APOA1/C3/A4/A5 cluster, ABCA1, CETP, GCKR, HL, IL-6, LPL, PLIN, and TCF7L2) to the modulation of the postprandial lipid metabolism. ...
In this study we have presented the current evidence linking a number of candidate genes (APOA1/C3/A4/A5 cluster, ABCA1, CETP, GCKR, …
Alternative C3 Complement System: Lipids and Atherosclerosis.
Garcia-Arguinzonis M, Diaz-Riera E, Peña E, Escate R, Juan-Babot O, Mata P, Badimon L, Padro T. Garcia-Arguinzonis M, et al. Int J Mol Sci. 2021 May 12;22(10):5122. doi: 10.3390/ijms22105122. Int J Mol Sci. 2021. PMID: 34066088 Free PMC article.
However, no correlation was identified between circulating C3 levels and the increase in plaque burden, indicating a local regulation of the C3 in AT arteries. ...C3mRNA was up-regulated in lipid-loaded human VSMCs, and C3 protein significantly increased in c …
However, no correlation was identified between circulating C3 levels and the increase in plaque burden, indicating a local regulation …
Osteoarthritis endotype discovery via clustering of biochemical marker data.
Angelini F, Widera P, Mobasheri A, Blair J, Struglics A, Uebelhoer M, Henrotin Y, Marijnissen AC, Kloppenburg M, Blanco FJ, Haugen IK, Berenbaum F, Ladel C, Larkin J, Bay-Jensen AC, Bacardit J. Angelini F, et al. Ann Rheum Dis. 2022 May;81(5):666-675. doi: 10.1136/annrheumdis-2021-221763. Epub 2022 Mar 4. Ann Rheum Dis. 2022. PMID: 35246457 Free article.
RESULTS: Three dominant endotypes were found, associated with three phenotypes: C1) low tissue turnover (low repair and articular cartilage/subchondral bone turnover), C2) structural damage (high bone formation/resorption, cartilage degradation) and C3) systemic inflammati …
RESULTS: Three dominant endotypes were found, associated with three phenotypes: C1) low tissue turnover (low repair and articular cartilage/ …
308 results